Skip to main content

plain-language-summary

Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.

Informations de source

Dépôt
K-Dense-AI/skill-101-webinar
Dernière activité de la source
7 juillet 2026 à 00:19
Langue détectée de SKILL.md
anglais
Étoiles
8
Forks
5

Options d'installation

Le prompt qui vérifie d'abord la source est sélectionné par défaut. Vous pouvez passer à une commande directe ou télécharger une copie locale.

Vérifiez les fichiers source

Lisez SKILL.md et les fichiers associés affichés par SkillsMP avant de décider de l'installer.

Affichage de SKILL.md

SKILL.md
Instructions source · Aperçu en lecture seule
name
plain-language-summary
description
Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.
# Plain-Language Summary ## When to use Any time the user wants technical, jargon-heavy, or dense material made clear for a general reader — abstracts, documentation, reports, emails, papers. ## Output format (ALWAYS use exactly this) **TL;DR:** one plain sentence anyone could understand. **Why it matters:** 1–2 sentences on the real-world significance. **Key points:** - 3–5 bullets, each jargon-free and self-contained. **Caveats:** what's uncertain, assumed, or out of scope (1–2 bullets). ## Rules - No jargon without a 3-word plain explanation in parentheses. - Prefer everyday words; cut filler. - Keep the whole thing under ~200 words unless the user asks for more. - Never invent facts that aren't in the source text; if something is unclear, say so in Caveats. ## Example Input: "We employed a randomized double-blind placebo-controlled trial (n=240) to assess the efficacy of compound X on LDL-C reduction over 12 weeks." Output: **TL;DR:** A careful study tested whether drug X lowers "bad" cholesterol, and it did. **Why it matters:** Lower bad cholesterol usually means lower heart-disease risk. **Key points:** - 240 people took part over 12 weeks. - Neither patients nor doctors knew who got the real drug (double-blind), which reduces bias. - Some got a fake pill (placebo) for comparison. **Caveats:** - 12 weeks is short — long-term effects aren't shown here.
Voir sur GitHub